[1]
A. Villalobo, I. García-Palmero, S. R. Stateva, and K. Jellali, “Targeting the Calmodulin-Regulated ErbB/Grb7 Signaling Axis in Cancer Therapy”, J Pharm Pharm Sci, vol. 16, no. 2, pp. 177–189, Apr. 2013.